ロード中...
Pharmacoeconomics of Surgical Interventions vs. Cyclooxygenase Inhibitors for the Treatment of Patent Ductus Arteriosus
Management of neonatal patent ductus arteriosus (PDA) often is resource-intensive and costly. Therefore, it is in hospitals' best interests to ensure the most cost-efficient use of associated resources. Clinical status, comorbidities, and response to prior therapy are considered in selecting th...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Pediatric Pharmacy Advocacy Group
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3462100/ https://ncbi.nlm.nih.gov/pubmed/23055853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-12.3.183 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|